Generic Singulair is used for prevention and long-term treatment of asthma. It is also used in certain patients to relieve runny nose caused by allergy and to prevent asthma attacks caused by exercise.
Montelukast not associated with decreased URIs - Pediatric SuperSite
Pediatric SuperSiteMontelukast not associated with decreased URIsPediatric SuperSiteTwelve weeks of treatment with 4 mg of the selective leukotriene receptor antagonist montelukast failed to help in preventing upper respiratory infections when compared with placebo, according to a study published online.
Merck predicts huge sales losses upon the expiry of protection for its ... - PR Web (press release)
Merck predicts huge sales losses upon the expiry of protection for its .
Merck & Co net zooms to $6.3 billion in 2011 - pharmabiz.com
BloombergMerck & Co net zooms to $6.
Glenmark consolidated net slips by 47% to - pharmabiz.com
Glenmark consolidated net slips by 47% topharmabiz.
Merck & Co back in profit, beats forecasts - The Pharma Letter
Globe and MailMerck & Co back in profit, beats forecastsThe Pharma LetterWorldwide sales of Singulair (montelukast), a once-a-day oral medicine indicated for the chronic treatment of asthma and the relief of symptoms of allergic rhinitis, grew 8% from the fourth quarter of 2010 to $1.